I
ImmunityBio
IBRX
4.77500
USD
-0.365
(-7.10%)
مغلق
حجم التداول
210,290
الربح لكل سهم
0
العائد الربحي
0
P/E
-5
حجم السوق
3,667,248,446
العنوان: ImmunityBio
القطاع: Healthcare
الصناعة: Biotechnology
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: United states and Europe. Key revenue is generated from Europe.